The Latest Breaking News from Sanofi

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

Twitter's new verification system shook Eli Lilly — leading LLY stock to skid Friday — after a fake account claimed "insulin is free now."

Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the Alzheimer’s treatment Aduhelm

Biogen and Seagen tapped new CEOs on Thursday but the biotech stocks diverged following the long-anticipated announcements.

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

Sanofi stock jumped Friday after the company reported better-than-expected third-quarter profit, leading to a guidance boost.

Exclusive: halt to production of Shanchol vaccine alarms WHO amid ‘unprecedented’ global outbreaks

Kind strangers have been donating dioralyte to help save an epileptic child after 'national shortage'